DETAILED NOTES ON BLOCK PAIN RECEPTORS WITH PROLEVIATE

The activation of CB1 and CB2 inhibits the development of intracellular cAMP, therefore leading to a tremendous reduction with the excitatory outcome within the neurons [88,89]. In addition, the activation of CB2 can additional stop the mast mobile degranulation and the release of professional-inflammatory mediators, producing the reduction in pain